Predictive Modeling for Chemotherapy Response Using Machine Learning
Abstract
One of the most difficult and urgent problems in oncology is still predicting how a patient will react to chemotherapy. Interpatient variability still restricts therapeutic success and increases the likelihood of side effects, even with major improvements in treatment regimens. Machine learning (ML) has been a game-changing technique in biomedical research in recent years, allowing high-dimensional information to be integrated and interpreted to inform clinical judgment. With an emphasis on both historical advancements and contemporary advances, this thesis offers a thorough analysis of the function of machine learning in predicting the results of chemotherapy. After examining the fundamental ideas and early applications of machine learning in oncology, we provide a thorough analysis of current supervised and unsupervised learning methods used in chemotherapy response prediction. Neural networks, random forests, support vector machines, and clustering algorithms are important techniques. The use of reputable public datasets as standards for model training and validation, including The Cancer Genome Atlas (TCGA), Genomics of Drug Sensitivity in Cancer (GDSC), and Cancer Cell Line Encyclopedia (CCLE), is also covered in the thesis.Particular focus is placed on real-world clinical application, model interpretability, and performance evaluation criteria. We also discuss data biases, generalizability issues, and ethical problems. Finally, by allowing for therapy customization…
How strong is the evidence?
Evidence Hub reads this as a simulation / modelling, done in computer models (in silico), not in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Improving the translation of search strategies using the Polyglot Search Translator: a randomized controlled trial
- Nutritional, Physical, Cognitive, and Combination Interventions and Frailty Reversal Among Older Adults: A Randomized Controlled Trial
- Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study
- A randomized, controlled trial of oral propranolol in infantile hemangioma
- Clinical phenotypes of delirium during critical illness and severity of subsequent long-term cognitive impairment: a prospective cohort study
- Increased physical activity improves sleep and mood outcomes in inactive people with insomnia: a randomized controlled trial
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.